search
Back to results

Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions

Primary Purpose

Dental Caries

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Curodont Repair
Fluoride
Sponsored by
Credentis AG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Caries focused on measuring Dental caries, Curodont Repair, P11-4

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Two approximal carious lesions on different teeth with at least one tooth in between
  2. Both study lesions must not require an invasive treatment
  3. Size and form of the lesions: the lesions must be fully visible and assessable on radiographs
  4. The two carious lesions must fall into classes:

    • D2 (inner half of enamel)
    • D3 (outer part of dentine) but only if very little dentine is involved (enamel-dentine junction)
  5. Able and willing to observe good oral hygiene throughout the study
  6. Age ≥ 18 years and ≤ 65 years
  7. Willing and able to attend the on-study visits
  8. Willing and able to understand all study-related procedures
  9. Written informed consent before participation in the study

Exclusion Criteria:

  1. The two study test lesions are located on adjacent teeth
  2. Fluoride varnish application < 3 months prior to study treatment
  3. Tooth with numerous carious lesions
  4. Evidence of tooth erosion
  5. History of head and neck illnesses (e.g. head/neck cancer)
  6. Any pathology or concomitant medication affecting salivary flow or dry mouth
  7. Any metabolic disorders affecting bone turnover
  8. Patient suffers from diabetes
  9. Concurrent participation in another clinical trial
  10. Women who are breast-feeding, pregnant or who plan a pregnancy during the study
  11. Women of childbearing potential who declare being unwilling or unable to practice contraception such as hormonal contraceptives, sexual abstinence or intercourse with a vasectomised partner

Sites / Locations

  • Zahnheilkunde Seifert Gmbh

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Curodont Repair

Fluoride

Arm Description

Application on Day 0 and Day 360

Application on Day 0, Day 180, Day 360, Day 540

Outcomes

Primary Outcome Measures

Opaqueness on X-Ray
The primary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 0 to Day 365 between test and control group.

Secondary Outcome Measures

Additional benefit of a second Curodont Repair application
The secondary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 360 to Day 720 between test and control group.

Full Information

First Posted
March 21, 2014
Last Updated
July 17, 2018
Sponsor
Credentis AG
search

1. Study Identification

Unique Protocol Identification Number
NCT02101255
Brief Title
Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions
Official Title
Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised, Split-mouth, Post-marketing Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
July 2014 (undefined)
Primary Completion Date
June 26, 2017 (Actual)
Study Completion Date
June 26, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Credentis AG

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the treatment of early approximal carious lesions compared to fluoride.
Detailed Description
All study participants must have two early approximal carious lesions in need of a treatment but not of an invasive treatment (split-mouth design). One lesion will be treated with Curodont Repair and one with fluoride as control. Study duration is 24 months. For assessment x-ray pictures, Diagnodent Pen and DiagnoCam is used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries
Keywords
Dental caries, Curodont Repair, P11-4

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Curodont Repair
Arm Type
Experimental
Arm Description
Application on Day 0 and Day 360
Arm Title
Fluoride
Arm Type
Active Comparator
Arm Description
Application on Day 0, Day 180, Day 360, Day 540
Intervention Type
Device
Intervention Name(s)
Curodont Repair
Other Intervention Name(s)
P11-4
Intervention Description
Self-assembling peptide, biomimetic re-mineralisation Application on Day 0 and Day 360
Intervention Type
Device
Intervention Name(s)
Fluoride
Other Intervention Name(s)
Duraphat
Intervention Description
Application on Day 0, Day 180, Day 360, Day 540
Primary Outcome Measure Information:
Title
Opaqueness on X-Ray
Description
The primary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 0 to Day 365 between test and control group.
Time Frame
Day 360
Secondary Outcome Measure Information:
Title
Additional benefit of a second Curodont Repair application
Description
The secondary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 360 to Day 720 between test and control group.
Time Frame
Day 720

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Two approximal carious lesions on different teeth with at least one tooth in between Both study lesions must not require an invasive treatment Size and form of the lesions: the lesions must be fully visible and assessable on radiographs The two carious lesions must fall into classes: D2 (inner half of enamel) D3 (outer part of dentine) but only if very little dentine is involved (enamel-dentine junction) Able and willing to observe good oral hygiene throughout the study Age ≥ 18 years and ≤ 65 years Willing and able to attend the on-study visits Willing and able to understand all study-related procedures Written informed consent before participation in the study Exclusion Criteria: The two study test lesions are located on adjacent teeth Fluoride varnish application < 3 months prior to study treatment Tooth with numerous carious lesions Evidence of tooth erosion History of head and neck illnesses (e.g. head/neck cancer) Any pathology or concomitant medication affecting salivary flow or dry mouth Any metabolic disorders affecting bone turnover Patient suffers from diabetes Concurrent participation in another clinical trial Women who are breast-feeding, pregnant or who plan a pregnancy during the study Women of childbearing potential who declare being unwilling or unable to practice contraception such as hormonal contraceptives, sexual abstinence or intercourse with a vasectomised partner
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mathias Seifert, Med. dent.
Organizational Affiliation
Zahnheilkunde Seifert Gmbh
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zahnheilkunde Seifert Gmbh
City
Sirnach
State/Province
Thurgau
ZIP/Postal Code
8370
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
23969679
Citation
Brunton PA, Davies RP, Burke JL, Smith A, Aggeli A, Brookes SJ, Kirkham J. Treatment of early caries lesions using biomimetic self-assembling peptides--a clinical safety trial. Br Dent J. 2013 Aug;215(4):E6. doi: 10.1038/sj.bdj.2013.741.
Results Reference
background

Learn more about this trial

Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions

We'll reach out to this number within 24 hrs